캐나다 - 영어 - Health Canada

ivax pharmaceuticals incorporated - dobutamine (dobutamine hydrochloride) - solution - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists

캐나다 - 영어 - Health Canada

sandoz canada incorporated - dobutamine (dobutamine hydrochloride) - liquid - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - dobutamine hydrochloride 14 mg/ml - eq. dobutamine 12,5 mg/ml - concentrate for solution for infusion - 250 mg/20 ml - dobutamine hydrochloride 14 mg/ml - dobutamine

몰타 - 영어 - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

primex pharmaceuticals oy - dobutamine hydrochloride - concentrate for soln for inf - 50

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

viatris limited - dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg - concentrate for infusion - 50 mg/ml - active: dobutamine hydrochloride 56.05mg equivalent to dobutamine 50 mg excipient: ascorbic acid water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive beta-adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially non-cardiac in origin 1. acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. when dobutamine hydrochloride is used for this purpose, as is the case when exercise is used for stress testing, patients should be informed of the potential risks involved in the test. in addition, patients should be subjected to the same close monitoring that is mandatory in standard exercise stress tests, including continuous electrocardiographic monitoring.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine excipient: sodium metabisulfite water for injection

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine - solution for infusion - 0.5 mg/ml - active: dobutamine hydrochloride 0.56 mg/ml equivalent to 0.5 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 1.12 mg/ml equivalent to 1 mg/ml dobutamine - solution for infusion - 1 mg/ml - active: dobutamine hydrochloride 1.12 mg/ml equivalent to 1 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine - solution for infusion - 2 mg/ml - active: dobutamine hydrochloride 2.24 mg/ml equivalent to 2.0 mg/ml dobutamine excipient: disodium edetate dihydrate glucose monohydrate sodium metabisulfite water for injection